1. Foreword

   • Christian Trépo
   • Rafael Esteban

   EditorialNotes Pages: 1S - 2S

2. Hepatitis C virus

   • Sheila Sherlock

   OriginalPaper Pages: 3S - 5S

3. Hepatitis C virus

   • Christian Bréchot

   OriginalPaper Pages: 6S - 21S

4. Magnitude and management of HCV infection in France

   • Christian Trépo
   • François Bailly

   OriginalPaper Pages: 22S - 26S

5. Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups

   • Hans L. Tillmann
   • Michael P. Manns

   OriginalPaper Pages: 27S - 40S

6. Patterns of progression

   • Nicolaos C. Tassopoulos

   OriginalPaper Pages: 41S - 48S

7. Risk factors and prevention of hepatocellular carcinoma in HCV infection

   • Luisa Benvegnù
   • Alfredo Alberti

   OriginalPaper Pages: 49S - 55S

8. Modeling therapeutic benefit in the midst of uncertainty

   • William G. Bennett
   • Stephen G. Pauker
   • John B. Wong

   OriginalPaper Pages: 56S - 62S

9. Nonhepatic manifestations and combined diseases in HCV infection

   • Stephanos J. Hadziyannis

   OriginalPaper Pages: 63S - 74S

10. Health assessment for chronic HCV infection

    • Robert L. Carithers Jr.
    • David Sugano
    • Martha Bayliss

    OriginalPaper Pages: 75S - 80S

11. High-dose interferon-α_2b treatment prevents chronicity in acute hepatitis C

    • Wolfgang Vogel
    • Ivo Graziadei
    • Josef Patsch

    OriginalPaper Pages: 81S - 85S

12. Duration of HCV infection as a predictor of nonresponse to interferon

    • Antonio craxì
    • Vito Di Marco
    • Silvio Magrin

    OriginalPaper Pages: 86S - 92S

13. Two years versus six months of interferon therapy for chronic hepatitis C

    • Geoffrey C. Farrell

    OriginalPaper Pages: 93S - 98S

14. Treatment of chronic hepatitis C by interferon for longer duration than six months

    • Thierry Poynard
    • Vincent Leroy
    • Jean Pierre Zarski

    OriginalPaper Pages: 99S - 102S

15. Dose increase augments response rate to interferon-α in chronic hepatitis C

    • Peter Ferenci
    • Rudolf Stauber
    • Alfred Gangl

    OriginalPaper Pages: 103S - 108S

16. Short-term versus sustained response to interferon therapy

    • Olle Reichard

    OriginalPaper Pages: 109S - 114S

17. Predictors of response to interferon therapy

    • Giorgio Saracco
    • Mario Rizzetto

    OriginalPaper Pages: 115S - 120S

18. Managing patients on interferon therapy

    • Rafael Esteban

    OriginalPaper Pages: 121S - 125S

19. Interferon-α therapy for chronic hepatitis C in special patient populations

    • Patrick Marcellin
    • Nathalie Boyer
    • Serge Erlinger

    OriginalPaper Pages: 126S - 130S

20. Interferon-ribavirin combination therapy for chronic hepatitis C

    • Solko W. Schalm
    • J. T. Brouwer
    • O. Weiland

    OriginalPaper Pages: 131S - 134S

21. Conference participants

    Legacy Pages: 135S - 135S